RETRACTION: LncRNA GAS6-AS1 facilitates the progression of breast cancer by targeting the miR-324-3p/SETD1A axis to activate the PI3K/AKT pathway (Retraction of Vol 99, 2020)

被引：0
|
作者：
Li, Sijie [1 ]
Jia, Hongyao [1 ]
Zhang, Zhiru [1 ]
Wu, Di [1 ]
机构：
[1] First Hosp Jilin Univ, Dept Breast Surg, Changchun 130021, Jilin, Peoples R China
来源：
EUROPEAN JOURNAL OF CELL BIOLOGY | 2023年 / 102卷 / 01期
关键词：
D O I：
10.1016/j.ejcb.2022.151269
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] RETRACTED: LncRNA GAS6-AS1 facilitates the progression of breast cancer by targeting the miR-324-3p/SETD1A axis to activate the PI3K/AKT pathway (Retracted article. See vol. 102, 2023)
    Li, Sijie
    Jia, Hongyao
    Zhang, Zhiru
    Wu, Di
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2020, 99 (08)
  • [2] RETRACTION: SNHG1 Promotes Malignant Progression of Glioma by Targeting miR-1405p and Regulating PI3K/AKT Pathway (Retraction of Vol 12, Pg 12011, 2020)
    Cai, R. D.
    Zhang, C. C.
    Xie, L. L.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7645 - 7645
  • [3] RETRACTION: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis (Retraction of Vol 19, art no 85, 2020)
    Liang, Yiran
    Song, Xiaojin
    Li, Yaming
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Zhang, Hanwen
    Liu, Ying
    Han, Dianwen
    Zhang, Ning
    Ma, Tingting
    Wang, Yajie
    Ye, Fangzhou
    Luo, Dan
    Li, Xiaoyan
    Yang, Qifeng
    MOLECULAR CANCER, 2022, 21 (01)
  • [4] RETRACTION: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p (Retraction of Vol 22, Pg 728, 2022)
    Wang, Zhen
    Wei, Yanting
    Zhu, Hao
    Yu, Lingfeng
    Zhu, Jie
    Han, Qixiu
    Liu, Ziying
    Huang, Jianhao
    Zhu, Yan
    Fan, Gentao
    Tang, Qikai
    Qian, Ji
    Chen, Xi
    Zhou, Guangxin
    BMC CANCER, 2023, 23 (01)
  • [5] RETRACTION: AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway (Retraction of Vol 20, art no 5526, 2019)
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [6] Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p
    Zhen Wang
    Yanting Wei
    Hao Zhu
    Lingfeng Yu
    Jie Zhu
    Qixiu Han
    Ziying Liu
    Jianhao Huang
    Yan Zhu
    Gentao Fan
    Qikai Tang
    Ji Qian
    Xi Chen
    Guangxin Zhou
    BMC Cancer, 23 (1)
  • [7] RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway
    Xu, L.
    Chen, J.
    Jia, L.
    Chen, X.
    Moumin, F. A.
    Cai, J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (15)
  • [8] RETRACTION: FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway (Retraction of Vol 23, Pg 9978, 2019)
    Li, Z. -Q.
    Qu, M.
    Wan, H. -X.
    Wang, H.
    Deng, Q.
    Zhang, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2159 - 2159
  • [9] RETRACTION: LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma (Retraction of Vol 19, art no 1533033820957023, 2020)
    Song, X.
    Ren, X.
    Xu, X.
    Ruan, X.
    Wang, Y.
    Yao, T. -T
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [10] RETRACTION: LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma (Retraction of Vol 19, art no 1533033820957023, 2020)
    Song, X.
    Ren, X.
    Xu, X.
    Ruan, X.
    Wang, Y.
    Yao, T. T.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
12345